Skip to main content

Advertisement

SpringerLink
Log in

Low-dosage active vitamin D modifies the relationship between hypocalcemia and overhydration in patients with advanced chronic kidney disease

  • Research Letter
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

Data cannot be shared publicly as data contain potentially identifying or sensitive patient information. The de-identified data are available upon request to Medical Center for Translational Research Osaka University Hospital (E-mail: mirai@hp-mctr.med.osaka-u.ac.jp). The data are available only after the approval of the Ethics Committee.

References

  1. Maiya S, Sullivan I, Allgrove J, Yates R, Malone M, Brain C et al (2008) Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart 94(5):581–584

    Article  CAS  PubMed  Google Scholar 

  2. Válek M, Roblová L, Raška I Jr, Schaffelhoferová D, Paleček T (2020) Hypocalcaemic cardiomyopathy: a description of two cases and a literature review. ESC Heart Fail 7(3):1291–1301

    Article  PubMed  PubMed Central  Google Scholar 

  3. Yamaguchi S, Hamano T, Doi Y, Oka T, Kajimoto S, Kubota K et al (2020) Hidden Hypocalcemia as a Risk Factor for Cardiovascular Events and All-Cause Mortality among Patients Undergoing Incident Hemodialysis. Sci Rep 10(1):4418

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Jensen AC, Polcwiartek C, Søgaard P, Mortensen RN, Davidsen L, Aldahl M, Eriksen MA et al (2019) The association between serum calcium levels and short-term mortality in patients with chronic heart failure. Am J Med 132(2):200–208

    Article  CAS  PubMed  Google Scholar 

  5. J-DAVID Investigators; Shoji T, Inaba M, Fukagawa M, Ando R, Emoto M, Fujii H, et al. Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial. JAMA. 2018 Dec 11;320(22):2325–2334.

  6. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ (2008) Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 102(11):1540–1544

    Article  CAS  PubMed  Google Scholar 

  7. Tamayo M, Manzanares E, Bas M, Martín-Nunes L, Val-Blasco A, Jesús Larriba M et al (2017) Calcitriol (1,25-dihydroxyvitamin D3) increases L-type calcium current via protein kinase A signaling and modulates calcium cycling and contractility in isolated mouse ventricular myocytes. Heart Rhythm 14(3):432–439

    Article  PubMed  Google Scholar 

  8. Witte KK, Byrom R, Gierula J, Paton MF, Jamil HA, Lowry JE et al (2016) Effects of Vitamin D on cardiac function in patients with chronic HF: the VINDICATE study. J Am Coll Cardiol 67(22):2593–2603

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sueta S, Morozumi K, Takeda A, Horike K, Otsuka Y, Shinjo H et al (2015) Ability of vitamin D receptor activator to prevent pulmonary congestion in advanced chronic kidney disease. Clin Exp Nephrol 19(3):371–378

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funding was received to assist with the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan

    Satoshi Yamaguchi & Yoshitaka Isaka

  2. Department of Nephrology, Japan Community Healthcare Organization Osaka Hospital, Osaka, Japan

    Satoshi Yamaguchi

  3. Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

    Takayuki Hamano

  4. Department of Nephrology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Japan

    Sayoko Yonemoto & Naohiko Fujii

Authors
  1. Satoshi Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takayuki Hamano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sayoko Yonemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naohiko Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshitaka Isaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SY, TH, and YI contributed to the study design. All authors were involved in data acquisition and interpretation of the results. SY and TH performed data analysis. SY and TH drafted the manuscript and the other authors critically revised the manuscript. Supervision was performed by TH and YI.

Corresponding author

Correspondence to Takayuki Hamano.

Ethics declarations

Conflict of interest

N.F. received honoraria from Chugai Pharmaceutical Co. Ltd., while all other authors of this manuscript declare no conflicts of interest.

Ethical approval and Informed consent

The Ethics Committee of Osaka University Hospital approved this study and waived the requirement for informed consent (Approval Number: 18026). The patients were allowed to opt out of the study. This study was conducted in accordance with the principles of the Declaration of Helsinki.

Human and animal rights

This study complies with the guidelines for human studies. No animals were utilized for this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 378 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamaguchi, S., Hamano, T., Yonemoto, S. et al. Low-dosage active vitamin D modifies the relationship between hypocalcemia and overhydration in patients with advanced chronic kidney disease. J Nephrol 37, 535–538 (2024). https://doi.org/10.1007/s40620-023-01801-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-023-01801-x

Search

Navigation